Epigenetic reprogramming is a process by which epigenetic modifications are altered, leading to changes in gene expression without changing the underlying DNA sequence. This process is important for normal development, but can also be used to reprogram cells and alter their fate. Epigenetic reprogramming can be achieved through various molecular mechanisms such as DNA methylation, histone modification, and non-coding RNA-mediated regulation. The process of epigenetic reprogramming is thought to be a key mechanism of plasticity during development and in response to environmental stimuli. It plays a role in the regulation of gene expression and can be used to reprogram cells from one type to another. For example, it has been used to reprogram adult cells into induced pluripotent stem cells (iPSCs) which have the potential to differentiate into any cell type in the body. Epigenetic reprogramming is also involved in diseases such as cancer and neurological disorders. Aberrant epigenetic reprogramming can lead to changes in gene expression that can contribute to the development of these diseases. This has led to increasing interest in epigenetic therapies which target epigenetic modifications to correct abnormal gene expression.
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin Khameh, Baylor College of Medicine, United States
Title : Application of thread technology in aesthetic and functional gynecology
Marlen Sulamanidze, Total Charm Clinic, Georgia
Title : Exploitation of sperm agglutination factor derived from Staphylococcus aureus as a putative candidate for vaginal contraception
Vijay Prabha, Panjab University, India
Title : Pregnancy outcome after uterine artery embolization for uterine adenomyosis: A systematic review and meta-analysis
Mohamed M Hosni, London North West University Healthcare NHS Trust, United Kingdom
Title : Endometrial functions in recurrent pregnancy loss
Nicoletta Di Simone, Humanitas University Milan, Italy
Title : The dawn of biological restoration in female pelvic floor and vulvovaginal disorders
Irene Eirini Orfanoudaki, University Hospital, Greece